SUBSCRIBE
SUBSCRIBE
News   FDA

Bayer AG Anticoagulant Drug Wins EU Green Light

July 25, 2008 | 
1 min read
LONDON, July 25 (Reuters) - Bayer AG's experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency, lifting the German company's share price.
FDA Approvals Europe
MORE ON THIS TOPIC
FDA CDER director George Tidmarsh speaking in an FDA video
Regulatory
FDA’s Tidmarsh Singles Out Aurinia’s Drug in LinkedIn Post About Surrogate Endpoints
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Exterior view of the headquarters of the
Regulatory
6 FDA Decisions To Watch For in Q4
September 29, 2025
 · 
9 min read
 · 
Tristan Manalac
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VI
Breast cancer
Lilly’s Oral SERD Wins FDA Go-Ahead for Breast Cancer
September 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Rare diseases
FDA Approves Crinetics’ Once-Daily Acromegaly Treatment
September 25, 2025
 · 
2 min read
 · 
Dan Samorodnitsky